56k a year!
Biogen Alzheimer’s drug approval was 'surprising for a lot of people': Eli Lilly CEO
The approval this month of an Alzheimer's drug from biotech company Biogen (BIIB) — along with the t
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论